Chengdu Kanghua Biological Products - Asset Resilience Ratio

Latest as of March 2024: 1.19%

Chengdu Kanghua Biological Products (300841) has an Asset Resilience Ratio of 1.19% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 300841 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥50.00 Million

≈ $7.32 Million USD Cash + Short-term Investments

Total Assets

CN¥4.20 Billion

≈ $614.85 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2020)

This chart shows how Chengdu Kanghua Biological Products's Asset Resilience Ratio has changed over time. See shareholders equity of Chengdu Kanghua Biological Products for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Chengdu Kanghua Biological Products's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Chengdu Kanghua Biological Products market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥50.00 Million	1.19%
Total Liquid Assets	CN¥50.00 Million	1.19%

Asset Resilience Insights

Limited Liquidity: Chengdu Kanghua Biological Products maintains only 1.19% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Chengdu Kanghua Biological Products Industry Peers by Asset Resilience Ratio

Compare Chengdu Kanghua Biological Products's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Argen-X F:1AE	Biotechnology	25.67%
Tubize-Fin BR:TUB	Biotechnology	0.05%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
Dashenlin Pharm Grp Co Ltd SHG:603233	Biotechnology	0.02%
Staidson Beijing Biopharma SHE:300204	Biotechnology	7.93%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	41.25%
Ardelyx Inc NASDAQ:ARDX	Biotechnology	41.14%
Xiangxue Pharmaceutical SHE:300147	Biotechnology	0.05%

Annual Asset Resilience Ratio for Chengdu Kanghua Biological Products (2020–2020)

The table below shows the annual Asset Resilience Ratio data for Chengdu Kanghua Biological Products.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2020-12-31	8.38%	CN¥180.00 Million ≈ $26.34 Million	CN¥2.15 Billion ≈ $314.27 Million	--

pp = percentage points

About Chengdu Kanghua Biological Products

SHE:300841 China Biotechnology

Market Cap

$1.09 Billion

CN¥7.42 Billion CNY

Market Cap Rank

#8756 Global

#2306 in China

Share Price

CN¥57.08

Change (1 day)

-0.90%

52-Week Range

CN¥52.31 - CN¥92.06

All Time High

CN¥399.08